Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease, on Dialysis.

NCT02174731 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2133

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: Roxadustat
DRUG: Epoetin alfa

Sponsor

AstraZeneca

Collaborators

[object Object]